CCR-2 antagonist salt

Details for Australian Patent Application No. 2004287416 (hide)

International Classifications

Event Publications

18 May 2006 PCT application entered the National Phase

PCT publication WO2005/044264 Priority application(s): WO2005/044264

19 November 2009 Application Accepted

Published as AU-B-2004287416

28 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

18 March 2010 Standard Patent Sealed

6 May 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 25 Feb 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

9 September 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 25 Feb 2010 2005

11 October 2012 Alteration of Name

The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.